U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822334) titled 'A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease' on Sept. 11.
Brief Summary: This study will evaluate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and pharmacodynamics (PD) of single and multiple doses of RO7830698 in healthy participants and participants with chronic obstructive pulmonary disease (COPD).
Study Start Date: Oct. 20
Study Type: INTERVENTIONAL
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Healthy Participants
Intervention:
DRUG: RO7830698
Participants will receive RO7830698 as per the schedule described in the protocol.
DRUG...